EUVIMEDEUVIMED entdecken
Crossref

Lipid Nanoparticle-Mediated Delivery of 27-Hydroxycholesterol for Targeting Rhinovirus-Induced Respiratory Diseases

Mathieu Repellin, Matteo Costantino iD, Rachele Francese, Pierre-Yves Dugas iD, Giuseppe Poli, David Lembo iD, Andrea Civra, Giovanna Lollo iD

Molecular Pharmaceutics · 06.04.2026 · 23 (4) · 2362-2372

DOI: 10.1021/acs.molpharmaceut.5c01299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 20.03.2026. Verfasst von Mathieu Repellin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Université Claude Bernard Lyon 1, CNRS LAGEPP UMR 5007, Villeurbanne 69100, France. Hauptthemen laut MEDLINE: Rhinovirus, Nanoparticles, Hydroxycholesterols, Antiviral Agents. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhinovirusNanoparticlesHydroxycholesterolsAntiviral AgentsLipidsPicornaviridae InfectionsHumansHeLa CellsCell SurvivalVirus ReplicationDrug Delivery SystemsNasal MucosaLiposomes

Stichwörter der Autor:innen

antiviral therapynanomedicinenasal deliveryoxysterols

Substanzen

HydroxycholesterolsAntiviral Agents27-hydroxycholesterolLipidsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Université Claude Bernard Lyon 1, CNRS LAGEPP UMR 5007, Villeurbanne 69100, France.
  • Department of Clinical and Biological Sciences, University of Turin, Orbassano 10043, Italy.
  • Université Claude Bernard Lyon 1, CNRS CP2M UMR 5128, Villeurbanne 69100, France.
  • Institut universitaire de France (IUF), Paris 75231, France.

ORCID-Profile: Matteo Costantino, Pierre-Yves Dugas, David Lembo, Giovanna Lollo

Förderung

  • Agence Nationale de la Recherche
  • NextGenerationEU

Zitieren

APA

Repellin, M., Costantino, M., Francese, R., Dugas, P. Y., Poli, G., Lembo, D., Civra, A., & Lollo, G. (2026). Lipid Nanoparticle-Mediated Delivery of 27-Hydroxycholesterol for Targeting Rhinovirus-Induced Respiratory Diseases. Molecular Pharmaceutics, 23(4), 2362-2372. https://doi.org/10.1021/acs.molpharmaceut.5c01299

Vancouver

Repellin M, Costantino M, Francese R, Dugas PY, Poli G, Lembo D, et al. Lipid Nanoparticle-Mediated Delivery of 27-Hydroxycholesterol for Targeting Rhinovirus-Induced Respiratory Diseases. Molecular Pharmaceutics. 2026;23(4):2362-2372. doi:10.1021/acs.molpharmaceut.5c01299

BibTeX
@article{Repellin2026,
  author = {Repellin, Mathieu and Costantino, Matteo and Francese, Rachele and Dugas, Pierre-Yves and Poli, Giuseppe and Lembo, David and Civra, Andrea and Lollo, Giovanna},
  title = {Lipid Nanoparticle-Mediated Delivery of 27-Hydroxycholesterol for Targeting Rhinovirus-Induced Respiratory Diseases},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {4},
  pages = {2362--2372},
  doi = {10.1021/acs.molpharmaceut.5c01299}
}
Kostenlos starten →